Skip to main content
Niti Goel, MD, Rheumatology, Durham, NC

NitiGoelMD

Rheumatology • Durham, NC

Adjunct Assistant Professor in the Department of Medicine, Duke University School of Medicine and Co-founder, Caduceus Biomedical Consulting, LLC

Join to view full profile

Dr. Goel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Goel's full profile

Already have an account?

  • Office

    508 Fulton St
    Durham, NC 27705
    Phone+1 828-257-2333

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Rheumatology, 1993 - 1995
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1990 - 1993
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1990

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2008 - 2025
  • NC State Medical License
    NC State Medical License 2016 - 2025
  • TX State Medical License
    TX State Medical License 1996 - 2008
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow American College of Rheumatology

Publications & Presentations

PubMed

Press Mentions

  • Black, Hispanic Patients Underrepresented in PsA Clinical Trials
    Black, Hispanic Patients Underrepresented in PsA Clinical TrialsDecember 2nd, 2022
  • Abcuro to Present Late-Breaking Abstract at American College of Rheumatology Convergence 2021 of ABC008 Inclusion Body Myositis Phase 1 Data Demonstrating Proof of Mechanism for Selective Depletion of Highly Cytotoxic T Cells
    Abcuro to Present Late-Breaking Abstract at American College of Rheumatology Convergence 2021 of ABC008 Inclusion Body Myositis Phase 1 Data Demonstrating Proof of Mechanism for Selective Depletion of Highly Cytotoxic T CellsNovember 5th, 2021
  • Kezar Life Sciences Announces Promising Data from First in Patient Study of KZR-616 at EULAR 2019 Annual Meeting
    Kezar Life Sciences Announces Promising Data from First in Patient Study of KZR-616 at EULAR 2019 Annual MeetingJune 13th, 2019
  • Join now to see all

Professional Memberships

Other Languages

  • Hindi

Dr. Niti Goel, Dr. Niti Goel, MD, Dr. N Goel